James J. Bochnowski
David L. Douglass
John F. Maroney
Deepa R. Pakianathan, Ph.D.
Matthew T. Potter
Douglas A. Roeder
VISION
More Than Capital
Experience Counts
Our Focus

David L. Douglass
General Partner

Since 1979, David has been actively involved in managing and investing in over 50 high growth venture capital backed companies, primarily in the medical device industry. He joined Delphi Ventures in 1990. Prior to joining Delphi, David was a General Partner at Matrix Partners focusing on medical device investments.

From 1984 to 1986, David served as Chief Operating Officer at Paladin Software Corporation, responsible for operations, R&D, finance and administration. From 1979 to 1983, David was Vice President of Finance and Administration at Collagen Corporation. He was responsible for several private equity financings, as well as Collagen's initial public offering. Before joining Collagen, David was a consultant with McKinsey & Company and a Teaching Fellow at Athens College in Greece.

David is a trustee of the Stanford University DAPER Fund and is a member of the Stanford University School of Education Advisory Board. He has served as a director of the Stanford University Athletic Board. Additionally, David is an Adjunct Professor at The University of Hawaii teaching New Venture Management and is a member of the Medical Industry Group of the National Venture Capital Association. Previously, he served as a director of the Western Association of Venture Capital. Recently, David was named to the Forbes Midas List recognizing the top 100 venture capital investors.

EDUCATION

  • MA Stanford University Graduate School of Education
  • MBA Stanford University Graduate School of Business
  • BA cum laude Amherst College

REPRESENTATIVE BOARD INVOLVEMENT

  • Adiana, Inc. a.b. Cytec Corporation a.b. Hologic, Inc.
  • AneuRx, Inc. a.b. Medtronic, Inc. (MDT)
  • Aragon Surgical, Inc.
  • Arbor Surgical Technologies, Inc.
  • BaroSense, Inc.
  • BARRx, Inc.
  • Breathe Technologies, Inc.
  • Cameron Health, Inc.
  • Cardiac Pathways Corp. (CPWY) a.b. Boston Scientific Corp. (BSX)
  • Cygnus Therapeutic Systems, Inc. (CYGN)
  • EndoTex Interventional Systems, Inc. a.b. Boston Scientific Corp. (BSX)
  • GyneCare, Inc. (GYNE) a.b. Johnson & Johnson, Inc. (JNJ)
  • Innovasive Devices, Inc. (IDEA) a.b. Johnson & Johnson, Inc. (JNJ)
  • Interventional Technologies, Inc. a.b. Boston Scientific Corp. (BSX)
  • LipoSonix, Inc.
  • NeoForma.com (NEOF)
  • NeuroMetrix, Inc. (NURO)
  • NeuroVista Corporation
  • Novasys Medical, Inc.
  • Onux Medical, Inc. a.b. C.R. Bard, Inc. (BCR)
  • Oratec Interventions, Inc. (OTEC) a.b. Smith & Nephew, Inc. (SNN)
  • Reliant Technologies, Inc.
  • RITA Medical Systems, Inc. (RITA)
  • TheraTx, Inc. (THTX) a.b. Vencor, Inc. (VNCO)
  • TheraSense, Inc. (THER) a.b. Abbott Laboratories (ABT)
  • Thermage, Inc. (THER)
  • VidaMed, Inc. (VIDA) a.b. Medtronic, Inc. (MDT)
“At Delphi, we seek a positive, supportive and cooperative relationship with entrepreneurs. To work with such extraordinary individuals is an honor. We offer our extensive contacts and resource base, but know a company's success is due to the entrepreneurs and management teams that we support.”